Skip to content

The effect of intravenous lidocaine on the dosage of ciprofol in elderly patients undergoing colonoscopy

The effect of intravenous lidocaine on the dosage of ciprofol in elderly patients undergoing colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097572
Enrollment
Unknown
Registered
2025-02-20
Start date
2022-04-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonoscopy sedation

Interventions

Group L:intravenous injection of lidocaine
Group N:intravenous injection of normal saline

Sponsors

the first affiliated hospital of Shantou university medical college
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: Undergo a painless colonoscopy. Age> = 65 years. BMI 18-30 kg/m². ASAI.~III.

Exclusion criteria

Exclusion criteria: Allergy to related medications. Basal pulse oximetry < 90%. Severe heart, lung, and kidney disease. Mental disorders. Hyperalgesia or refractory cancer pain. Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
total consumption of ciprofol;

Secondary

MeasureTime frame
Satisfaction ratings (physicians, patients);frequency of airway modifications(head tilt and chin lift, mask oxygenation , tracheal intubation);Incidence of sedation-related adverse events (hypoxemia, hypotension, and need to suspend examinations for sedation-related reasons);recovery time;Incidence of adverse reactions (dizziness, nausea and vomiting, drowsiness);

Countries

China

Contacts

Public ContactKe Weiqi

the first affiliated hospital of Shantou university medical college

499262579@qq.com+86 138 2966 6612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026